Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 12 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
Requirements model comparative analysis method for effort estimation in customizing a network monitoring and control system
Active tags
Fabrication of high gradient insulators by stack compression
Data center with free-space optical communications
Protein purification
Potato cultivar F10
  Randomly Featured Patents
Envelope feedforward technique with power control for efficient linear RF power amplification
Labeled resin bottle
Radio tracking system and method of operation thereof
Separation of database transactions
Component having an integrated waveguide with deflected end faces
HGA rotational micro-actuator including an s-shaped frame and method of making thereof
Synthesis of erythromycin ethyl carbonate
Procedure for an examination of objects by the means of ultrasound waves
One-piece self-venting drain valve
Car crash protector